Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study
Academic Article
Publication Date:
2021
Short description:
Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study / Serranti, D., Nebbia, G., Cananzi, M., Nicastro, E., Di Dato, F., Nuti, F., Garazzino, S., Silvestro, E., Giacomet, V., Forlanini, F., Pinon, M., Calvo, P.L., Riva, S., Dodi, I., Cangelosi, A.M., Antonucci, R., Ricci, S., Bartolini, E., Mastrangelo, G., Trapani, S., et al.. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 0277-2116. - 72:1(2021), pp. 95-100. [10.1097/MPG.0000000000002900]
abstract:
Sofosbuvir/Ledipasvir (SOF/LDV) has been approved by the European Medicine Agency (EMA) for the treatment of children and adolescents (at least 3 years of age) with chronic hepatitis C (CHC) genotype 1, 3, and 4 infection. The aim of this study was to evaluate the efficacy and safety of SOF/LDV in adolescents (12 to <18 years old) with CHC in the real-world setting.
Iris type:
1.1 Articolo in rivista
List of contributors:
Serranti, Daniele; Nebbia, Gabriella; Cananzi, Mara; Nicastro, Emanuele; Di Dato, Fabiola; Nuti, Federica; Garazzino, Silvia; Silvestro, Erika; Giacomet, Vania; Forlanini, Federica; Pinon, Michele; Calvo, Pier Luigi; Riva, Silvia; Dodi, Icilio; Cangelosi, Antonina Marta; Antonucci, Roberto; Ricci, Silvia; Bartolini, Elisa; Mastrangelo, Greta; Trapani, Sandra; Lenge, Matteo; Gaio, Paola; Vajro, Pietro; Iorio, Raffaele; D'Antiga, Lorenzo; Indolfi, Giuseppe
Published in: